Glucagen(Glucagon)
NVO
Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Novo Nordisk A/S
$3.5M
Medicare cost, 2024
$3.5M
Medicare cost, 2024
Medicare drug plans spent $3.5 million on Glucagen (glucagon) in 2024, for 9,420 prescriptions and refills filled by 6,695 patients. Spending fell 28% from 2023 to 2024. Florida accounts for the most spending ($288,864, 8% of the total). It is made by Novo Nordisk A/S (NVO).
Medicare cost, 2024
$3.5M
-28.1% from 2023
Prescriptions
9,420
$373.73 per claim
Patients
6,695
4,738 prescribers
Total spending, 2024
$3.5M
$525.81 per patient
Questions and answers
How much does Medicare spend on Glucagen?
Medicare prescription drug plans paid $3.5M for Glucagen in 2024, for 9,420 prescriptions and refills to 6,695 patients (down 28.1% from 2023). The average cost per claim was $373.73.
Which state spends the most on Glucagen?
Florida had the highest Medicare cost for Glucagen in 2024: $289K for 804 claims, followed by Texas ($287K).
Who prescribes Glucagen the most?
Patrick J O'Brien, physical medicine and rehabilitation in Raleigh, NC, had the highest Medicare cost for Glucagen in 2024: 60 claims costing $21K.
Who makes Glucagen?
Glucagen is made by Novo Nordisk A/S (NVO), listed in the Medicare spending data as Novo Nordisk.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Glucagen was $3.5M in 2024, after a high of $18.2M in 2020.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Glucagen, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Patrick J O'Brien Raleigh, NC | Physical Medicine and Rehabilitation | 60 | 49 | $21K |
| Amanda L Eubanks Little Rock, AR | Nurse Practitioner | 27 | Under 11 | $15K |
| Brittany R Simpson Seymour, TN | Nurse Practitioner | 11 | Under 11 | $13K |
| Jaswinder Sidhu Oconomowoc, WI | Internal Medicine | 22 | Under 11 | $11K |
| Catherine M Vanvoorn Columbia, MO | Internal Medicine | 33 | Under 11 | $11K |
| Thomas J Ferrari Swainsboro, GA | Internal Medicine | 12 | Under 11 | $10K |
| Joseph B Walsh Bradenton, FL | Family Practice | 28 | 27 | $9,346 |
| Amelia R Kiser Glasgow, KY | Family Practice | 26 | 11 | $8,598 |
| Brandon M Roscoe Du Bois, PA | Family Practice | 26 | 20 | $8,580 |
| Rebekah A Moss Booneville, MS | Nurse Practitioner | 15 | Under 11 | $8,282 |
| David A Delliquadri Girard, OH | Family Practice | 23 | Under 11 | $8,172 |
| Heather M Smith Somerset, KY | Nurse Practitioner | 25 | 16 | $8,167 |
| Joseph A Carlucci Winter Haven, FL | Internal Medicine | 19 | 11 | $7,402 |
| Maulikkumar A Patel Gray, GA | Internal Medicine | 21 | Under 11 | $7,307 |
| Albert O Boyd Desoto, TX | Family Practice | 22 | 12 | $7,219 |
| Vivek Khetpal Durant, OK | Cardiology | 13 | Under 11 | $6,966 |
| 1578593422 | Pediatric Medicine | 12 | Under 11 | $6,945 |
| Clyde O Green Macon, GA | Family Practice | 20 | Under 11 | $6,857 |
| Christopher M Chappel Kissimmee, FL | Family Practice | 19 | Under 11 | $6,824 |
| Carlos A Vargas Asheville, NC | Family Practice | 18 | Under 11 | $6,818 |
| Christopher J Quinn Granger, IN | Family Practice | 13 | Under 11 | $6,762 |
| Radu I Ciubuc El Paso, TX | Internal Medicine | 19 | 12 | $6,203 |
| Michael D Satchell Albany, GA | Family Practice | 17 | Under 11 | $5,953 |
| Jerry A Cohen Narberth, PA | General Practice | 18 | 12 | $5,895 |
| Gerald R Woodard Daytona Beach Shores, FL | Family Practice | 16 | Under 11 | $5,893 |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 7,252 | 18,014 | 11,190 | $5.9M |
| 2023 | 6,403 | 14,156 | 9,502 | $4.9M |
| 2024 | 4,738 | 9,420 | 6,695 | $3.5M |
Makers, 2024
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novo Nordisk | 9,424 | $3.5M |
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through September 2026, 4,235 side-effect reports named glucagon, the active ingredient of Glucagen (reports from 2004 on). 3,277 of them (77.4%) were serious, 676 named a death and 2,037 named a hospital stay. The reactions named most often were drug ineffective, dyspnoea and acute kidney injury. 1,739 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
4,235
392 in 2025 (+6.2% from 2024)
Serious
77.4%
3,277 reports
Deaths named
676
16.0% of reports
Hospital stays
2,037
48.1% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Glucagen?
4,235 reports from 2004 through September 2026 named glucagon, the active ingredient of Glucagen. 3,277 of them (77.4%) were serious, 676 named a death and 2,037 named a hospital stay.
What are the most reported side effects of Glucagen?
389 reports named drug ineffective, the reaction named most often, followed by dyspnoea (375) and acute kidney injury (324). In the last 5 years the reaction named most often was dyspnoea (229 reports). A report can name several reactions.
How many side-effect reports named Glucagen in 2025?
392 reports were received in 2025 (+6.2% from 2024). 2026 so far: 264 reports through September 2026, and more keep arriving late.
Do side-effect reports prove that Glucagen caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Glucagen caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
- Other Medicare drug pages with glucagon: Gvoke Hypopen 2-Pack, Baqsimi, Glucagon Emergency Kit, Gvoke Hypopen 1-Pack, Gvoke Pfs 1-Pack Syringe, Gvoke Pfs 2-Pack Syringe, Gvoke
- Makers on the stock market:
NVO
XERS·NVO drug pipeline - Drug approvals (1 approval on file for glucagon) · Clinical trials · Medicare drug spending
Side-effect reports from official public data, counted per active ingredient (glucagon) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.